# Bioequivalence of Adapalene Topical Gel in Patients With Acne Vulgaris

> **NCT01182636** · PHASE1 · COMPLETED · sponsor: **Teva Pharmaceuticals USA** · enrollment: 601 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Adapalene
- **DRUG:** Differin®
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01182636
- **Lead sponsor:** Teva Pharmaceuticals USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 601 (ACTUAL)
- **Last updated:** 2010-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01182636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01182636, "Bioequivalence of Adapalene Topical Gel in Patients With Acne Vulgaris". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01182636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*